CMPH

Introduction

The landscape of global public health is currently undergoing an unprecedented structural transformation, shifting from a historical focus on commodity affordability to the more complex challenge of governing integrated health ecosystems. For over three decades, the concept of market shaping was largely synonymous with correcting failures in the pharmaceutical and vaccine sectors. Early interventions, such as the Blue Circle social marketing initiative in Indonesia during the 1970s and 1980s, used branding, price subsidies, and private retail networks to stimulate demand for essential health products such as condoms and oral rehydration salts (Legowo, G. F. 1991; Ezizika, O et al 2021). These successes paved the way for a more sophisticated generation of global commodity pricing strategies, where coordinated donor financing revolutionized markets for antiretroviral therapy, reducing prices for first-line treatments by more than 99 percent between 2000 and 2020 (WHO, 2025; World Bank, 2025a).

However, empirical evidence suggests that these product-focused successes are being overtaken by broader systemic shifts in emerging economies. Countries are transitioning away from a reliance on external aid toward domestic financing models characterized by rising middle-class incomes, substantial remittance liquidity, and the rapid digitalization of health infrastructure. This evolution is accompanied by the accelerating financialization of service delivery, where private equity (PE) firms and global asset managers consolidate fragmented provider networks into corporate chains, often prioritizing financial returns over clinical outcomes. Consequently, the traditional paradigm of market shaping must evolve into a framework of Integrated System Market Shaping (ISMS) that governs ownership structures, data ecosystems, and provider incentives alongside commodities.

The Conceptual Framework for Integrated System Market Shaping (ISMS)

Understanding the modern health economy in emerging markets requires a multidimensional analytical lens. The ISMS framework identifies five interacting domains:

• Macroeconomic Drivers: GDP growth and urbanization shift demand toward tertiary care, attracted by remittance flows that function as informal social insurance.
• Health Financing and Strategic Purchasing: Moving from passive reimbursement to active, value-based contracting that rewards quality over volume.
• Service Delivery Markets and Private Capital: Governing the entry of PE and institutional investors to prevent “stealth consolidation”.
• Digital Ecosystems and Information Governance: Treating digital health data as a public utility to prevent proprietary monopolies.
• Regulatory and Stewardship Architecture: Safeguarding competition and patient safety through antitrust and clinical audits.

Each domain creates feedback loops. For example, when high remittance liquidity meets a consolidated private provider market, it can inadvertently trigger price inflation if strategic purchasing capacity is weak.

Figure 1: Remittance Flows and Out-of-Pocket Health Spending: The Double-Edged Sword of Emerging Market Healthcare.

Figure 2: The Integrated System Market Shaping (ISMS) framework across five interdependent domains

Macroeconomic Determinants and the Remittance Nexus

The economic foundation of health systems in several emerging economies is increasingly anchored in cross-border labor mobility. Officially recorded remittances to LMICs reached nearly $700 billion in 2024, a 10% growth from the previous year (World Bank, 2025b; Migration Data Portal, 2025). In India, remittances in 2024 reached an estimated $137 billion, while in the Philippines, these flows account for 9.8% of GDP (World Bank, 2025b).

While these inflows enhance household resilience, they are unevenly distributed. Families with migrant members often bypass public queues for private specialty services, reinforcing the concentration of hospital capacity in urban centers. The lack of risk-pooling mechanisms contributes to high out-of-pocket (OOP) expenditure, which remains as high as 70% in Nigeria (WHO, 2025; OECD, 2025) (Table 1).

Table 1: Remittances, Out-of-Pocket Health Spending, and Current Healthcare Trends in Selected Emerging Markets.

Figure 3: Emerging economies offer diverse blueprints for navigating system transitions and shaping markets.

The Financialization of Service Delivery and Private Equity Expansion

As remittance liquidity stabilizes, PE firms have identified healthcare in emerging markets as a high-margin target for capital deployment. Global healthcare PE deal value reached record highs in 2025 (Bain & Company, 2026). This trend is characterized by the corporatization of medicine, using leveraged buyouts (LBOs) in which clinical entities are purchased with debt collateralized by the hospital’s own assets (Fuse Brown & Hall, 2024).

Clinical Risks and Staffing Cuts

Evidence suggests that PE acquisition is frequently followed by aggressive cost-cutting. Hospitals have been documented to reduce physician staffing by 19% and nursing staff by 43% post-acquisition (American Progress, 2024). Harvard researchers found that patient deaths in emergency departments increased by 13% at PE-acquired hospitals, a finding directly linked to these staffing reductions (HMS, 2023). Furthermore, inpatient wards saw a 25% increase in preventable adverse events, including a 38% increase in infections following central line placements (NIH, 2024) (Table 2).

Table 2: Key Private Equity Investment Strategies in Healthcare.

Digital Transformation: AI and Strategic Purchasing

While financialization poses risks, digitalization offers powerful tools for ISMS. India’s National Health Authority (NHA) has pioneered the use of AI to shift from reactive fraud detection to “proactive integrity management” within the Ayushman Bharat scheme (PIB, 2025; JPMS, 2024). In Indonesia, BPJS Kesehatan has integrated robotic process automation (RPA) through RACE and RAPID platforms, reducing claim correction times from several minutes to under 97 seconds (Asian Business Review, 2025).

However, generative AI has also supercharged healthcare fraud. Authorities noted that deepfake-related fraud attempts surged by 3,000% in 2023 (TruthScan, 2025). This technological arms race requires that market shaping include robust digital integrity frameworks and mandatory algorithmic transparency (OECD, 2024a; OECD, 2024b) (Table 3).

Table 3: Key Digital Health Interventions and Outcomes in India and Indonesia.

Infection Prevention and Antimicrobial Resistance: A Systemic Challenge

System market shaping must incorporate quality safeguards to address public health issues such as antimicrobial resistance (AMR), which contributes to 4.5 million deaths annually (WHO, 2025b). ARCH studies have revealed that LMICs have up to 20 times higher rates of bacterial colonization harboring resistant genes than in the US and Europe (CDC, 2024; MDPI, 2024). In Kenya, only 53.6% of assessed health facilities were able to perform cultures (GARDP, 2024). Strategic purchasing must move beyond price to link reimbursement to mandatory AMR reporting and hospital wastewater treatment standards (WEF, 2025; MTaPS, 2023) (Table 4).

Table 4: AMR and Infection Prevention Readiness Indicators Across Selected Emerging Markets.

The Evolving Role of Global Donors and Health Partnerships

As countries graduate from Gavi support, they face the risk of a “graduation cliff.” In Vietnam, a rapid shift to localized financing led to a decline in childhood immunization rates from 87% to 77% due to stockouts (Immunization Economics, 2025). Gavi Phase 6 (2026–2030) now includes a “Catalytic phase” for middle-income countries to decouple programmatic support from vaccine subsidies,